OA06811A - Procédé de préparation de nouveaux dérivés de pyridoxine. - Google Patents

Procédé de préparation de nouveaux dérivés de pyridoxine.

Info

Publication number
OA06811A
OA06811A OA57404A OA57404A OA06811A OA 06811 A OA06811 A OA 06811A OA 57404 A OA57404 A OA 57404A OA 57404 A OA57404 A OA 57404A OA 06811 A OA06811 A OA 06811A
Authority
OA
OAPI
Prior art keywords
preparation
pyridoxine derivatives
new
new pyridoxine
derivatives
Prior art date
Application number
OA57404A
Other languages
English (en)
French (fr)
Inventor
Marcel Urbain
Marcel Descamps
Original Assignee
Labaz Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz Nv filed Critical Labaz Nv
Publication of OA06811A publication Critical patent/OA06811A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
OA57404A 1980-05-19 1981-05-18 Procédé de préparation de nouveaux dérivés de pyridoxine. OA06811A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8016516 1980-05-19

Publications (1)

Publication Number Publication Date
OA06811A true OA06811A (fr) 1982-12-31

Family

ID=10513518

Family Applications (1)

Application Number Title Priority Date Filing Date
OA57404A OA06811A (fr) 1980-05-19 1981-05-18 Procédé de préparation de nouveaux dérivés de pyridoxine.

Country Status (32)

Country Link
US (1) US4374841A (de)
EP (1) EP0040591B1 (de)
JP (1) JPS5711966A (de)
AR (1) AR226356A1 (de)
AT (1) ATE3859T1 (de)
AU (1) AU542463B2 (de)
BG (1) BG35327A3 (de)
CA (1) CA1152080A (de)
CS (1) CS223842B2 (de)
DD (1) DD159071A5 (de)
DE (1) DE3160480D1 (de)
DK (1) DK217481A (de)
EG (1) EG15890A (de)
ES (1) ES8203845A1 (de)
FI (1) FI811525L (de)
GR (1) GR82343B (de)
HU (1) HU183441B (de)
IE (1) IE51179B1 (de)
IL (1) IL62602A (de)
IN (1) IN151915B (de)
IS (1) IS1183B6 (de)
MA (1) MA19147A1 (de)
NO (1) NO811680L (de)
NZ (1) NZ196766A (de)
OA (1) OA06811A (de)
PL (1) PL129213B1 (de)
PT (1) PT72992B (de)
RO (1) RO81943A (de)
SU (1) SU1077566A3 (de)
YU (1) YU126281A (de)
ZA (1) ZA812448B (de)
ZW (1) ZW9681A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663354A (en) * 1984-04-26 1987-05-05 Klinge Pharma Gmbh Use of etilefrin and etilefrin pivalate in the long term treatment of circulatory disorders not due to hypotonia
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
US6051587A (en) * 1998-04-16 2000-04-18 Medicure, Inc. Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
EP1169322B8 (de) 1999-03-08 2006-09-13 Medicure Inc. Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
AU5840200A (en) 1999-07-13 2001-01-30 Medicure Inc. Treatment of diabetes and related pathologies
EP1872797A3 (de) 1999-08-24 2008-04-02 Medicure International Inc. Behandlung kardiovaskulärer und verwandter Leiden
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
WO2001064692A1 (en) 2000-02-29 2001-09-07 Medicure International Inc. Cardioprotective phosphonates and malonates
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
ATE364595T1 (de) 2000-07-07 2007-07-15 Medicure Int Inc Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
JP4048166B2 (ja) * 2002-11-18 2008-02-13 三井製糖株式会社 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
US20070167411A1 (en) * 2003-03-27 2007-07-19 Medicure International Inc. Compositions for treating angina
JP2008505126A (ja) * 2004-07-07 2008-02-21 メディキュア インターナショナル インコーポレイテッド 血小板凝集薬を用いる併用療法
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
CA2585165A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
CA2632090A1 (en) * 2005-11-28 2007-05-31 Medicure International Inc. Selected dosage for the treatment of cardiovascular and related pathologies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
AR207133A1 (es) * 1973-02-20 1976-09-15 Ciba Geigy Ag Procedimiento para la elaboracion de derivados de 1-piridiloxi 1-pirimidiniloxi y 1-piraziniloxi-2-hidroxi-3-amino-propano
GB1485919A (en) * 1975-08-12 1977-09-14 Grindstedvaerket As Pyridine derivatives
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines

Also Published As

Publication number Publication date
IE811085L (en) 1981-11-19
CA1152080A (en) 1983-08-16
IN151915B (de) 1983-09-03
EP0040591B1 (de) 1983-06-22
SU1077566A3 (ru) 1984-02-29
IS2631A7 (is) 1981-11-11
MA19147A1 (fr) 1981-12-31
ZA812448B (en) 1982-04-28
IE51179B1 (en) 1986-10-29
IS1183B6 (is) 1985-05-13
AR226356A1 (es) 1982-06-30
RO81943B (ro) 1983-05-30
PT72992B (en) 1982-07-01
ATE3859T1 (de) 1983-07-15
BG35327A3 (en) 1984-03-15
DD159071A5 (de) 1983-02-16
YU126281A (en) 1984-02-29
ES502276A0 (es) 1982-04-01
IL62602A (en) 1984-06-29
HU183441B (en) 1984-05-28
GR82343B (de) 1984-12-13
FI811525L (fi) 1981-11-20
PL129213B1 (en) 1984-04-30
NZ196766A (en) 1984-02-03
ES8203845A1 (es) 1982-04-01
US4374841A (en) 1983-02-22
AU542463B2 (en) 1985-02-21
PL231193A1 (de) 1982-07-05
EP0040591A1 (de) 1981-11-25
EG15890A (en) 1987-03-30
JPS5711966A (en) 1982-01-21
NO811680L (no) 1981-11-20
IL62602A0 (en) 1981-06-29
DE3160480D1 (en) 1983-07-28
PT72992A (en) 1981-06-01
DK217481A (da) 1981-11-20
CS223842B2 (en) 1983-11-25
ZW9681A1 (en) 1982-01-20
RO81943A (ro) 1983-06-01
AU7053581A (en) 1981-11-26

Similar Documents

Publication Publication Date Title
OA06811A (fr) Procédé de préparation de nouveaux dérivés de pyridoxine.
OA06914A (fr) Procédé de préparation d'iminodiacides substitués.
OA07766A (fr) Procédé de préparation de dérivés de cephème.
OA05928A (fr) Nouveaux dérivés de céphalosporine, leur procédé de préparation.
DZ418A1 (fr) Dérivés de céphalosporine, leur procédé de préparation et leur application thérapeutique.
OA05444A (fr) Procédé de préparation de nouveaux dérivés benzhydrylsulfinyle.
OA07003A (fr) Préparation de nouveaux dérivés de la furo-(3,4-c) -pyridine.
OA04687A (fr) Procédé de préparation de nouveaux dérivés de l'indole.
RO82215A (ro) Procedeu pentru prepareaea unor derivati de tiazol
OA06563A (fr) Procédé de préparation de nouveaux dérivés d'indolizine.
OA05725A (fr) Procédé de préparation de dérivés d'acides hydroxy-aminophosphonique hydrocarbonés.
OA06951A (fr) Dérivés de la thiéno-pyridinone, leur procédé de préparation et leur application thérapeutique.
OA06486A (fr) Procédé de préparation de 9 aminoalkylfluorènes.
OA05385A (fr) Procédé de préparation de nouveaux dérivés phénoxy.
OA06356A (fr) Procédé de préparation de 2-chlorosulfinylazétidinones.
OA05260A (fr) Procédé de préparation de dérivés d'histidine.
OA05485A (fr) Procédé de préparation de nouveaux dérivés hétérocycliques.
OA06274A (fr) Procédé de préparation de nouveaux composés de type muramyl-péptide.
OA06258A (fr) Procédé de préparation de nouveaux dérivés acétyléniques de l'androst-4-ène.
OA06355A (fr) Procédé de préparation de 3-exométhylènecépham-sulfoxydes.
DZ687A1 (fr) Dérivés de la chlori-4-furo-(3,4-c)-pyridine et leur procédé de préparation.
OA05778A (fr) Procédé de préparation de dérivés l-(N-acylcarbamoyl) 2-cyano-aziridines.
OA07833A (fr) Procédé de préparation de nouveaux dérivés de 1-(acétylamino)-2-amino-propanone.
OA06879A (fr) Procédé de préparation de dérivés d'hétéroprostaglandines.
OA05295A (fr) Procédé de préparation de tétrazoles substitués.